- Biden Will Move to Have Medicare, Medicaid Cover GLP-1 Weight-Loss Meds
- Cold Plunge or Hot Bath? What’s Best for Ailing Muscles?
- Concussions Slow Brain Activity in High School Football Players
- Study Finds GLP-1 Meds Can Also Help the Kidneys
- Long COVID Brain Fog: Could the Lungs Hold Clues?
- Scientists Spot Gene That Could Help Cause Miscarriages
- Preschoolers’ Tantrums Can Be Early Sign of ADHD
- Mom’s Healthy Diet in Pregnancy Pays Big Dividends for Baby
- There’s a Best Option for Patients With Head-and-Neck Cancer Who Can’t Take Cisplatin
- Program Tripled Number of Completed At-Home Colon Cancer Tests
Smog May Shorten Lives of Lung Cancer Patients
Air pollution may shorten the lives of lung cancer patients, a new study suggests.
Researchers led by Sandrah Eckel, who’s with the department of preventive medicine at the University of Southern California in Los Angeles, analyzed data from more than 352,000 people in California who were diagnosed with lung cancer between 1988 and 2009.
Higher exposure to the pollutants nitrogen dioxide, ozone and airborne particles was associated with an increased risk of early death. The association was strongest in patients with early stage disease, particularly adenocarcinoma, which accounts for 80 percent of lung cancer cases, the researchers said.
Early stage patients with greater exposure to pollutants survived on average 2.4 years compared to 5.7 years for those with low exposure, the study found.
The study was published online Aug. 4 in the journal Thorax.
Since this was an observational study, no firm conclusion can be drawn about cause and effect, the researchers said. But they noted that the International Agency for Research on Cancer classifies air pollution as a cancer-causing agent.
“This study, along with two other previously published analyses on the impact of air pollution on cancer survival, provide compelling initial evidence that air pollution may be a potential target for future prevention and intervention studies to increase cancer survival,” Dr. Jaime Hart wrote in an accompanying journal editorial.
Hart is an epidemiologist at Brigham and Women’s Hospital in Boston.
More information
The U.S. National Cancer Institute has more on lung cancer.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.